Expression of galectin-1 and galectin-3 in human fetal thyroid gland.
High levels of expression of galectin-1 and galectin-3, the beta-galactoside-binding proteins, have been recently described in malignant thyroid tumors but not in adenomas nor in normal thyroid tissue. However, there are no data about the expression of these galectins during fetal thyroid development. In this study we analyzed immunohistochemically the presence of galectin-1 and galectin-3 in human fetal thyroid glands (16-37 weeks of gestation). Weak to moderate cytoplasmic staining for galectin-1 was observed in follicular cells of all fetal thyroids. Galectin-3 could not be detected in thyroid follicular cells of any fetal thyroid investigated. Both galectins were detected in stromal tissue, but staining for galectin-1 was more intense. The absence of galectin-3 in thyroid cells during fetal development suggests that galectin-3 is expressed de novo during malignant transformation of thyroid epithelium, and that galectin-1 could be considered an oncofetal antigen. The results obtained indicated potential roles for galectin-1 and galectin-3 during the investigated period of human fetal thyroid gland development. Both galectins might participate in developmental processes regarding stromal fetal thyroid tissue organization, whereas galectin-1 might have a function in thyroid epithelium maturation.
Savin
Svetlana B
SB
Institute for the Application of Nuclear Energy-INEP, University of Belgrade, Zemun-Belgrade, Yugoslavia.
Cvejić
Dubravka S
DS
Janković
Miroslava M
MM
D037483:Galectin 1 / Q000096:biosynthesis*; D037502:Galectin 3 / Q000096:biosynthesis*; D005865:Gestational Age; D006801:Humans; D007150:Immunohistochemistry; D013961:Thyroid Gland / Q000196:embryology / Q000378:metabolism*
D037483:Galectin 1; D037502:Galectin 3